Crestwood Advisors Group LLC Editas Medicine, Inc. Transaction History

Crestwood Advisors Group LLC

$5.07 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$7.03 - $11.53 $19,332 - $31,707	-2,750 Reduced 17.5%	12,960 $93,000
Q3 2022 Oct 26, 2022	SELL	$12.16 - $19.42 $24,320 - $38,840	-2,000 Reduced 11.29%	15,710 $192,000
Q2 2022 Jul 07, 2022	SELL	$9.99 - $21.35 $4,495 - $9,607	-450 Reduced 2.48%	17,710 $210,000
Q1 2022 Apr 12, 2022	SELL	$14.08 - $27.63 $16,192 - $31,774	-1,150 Reduced 5.96%	18,160 $345,000
Q4 2021 Feb 15, 2022	SELL	$26.55 - $40.57 $31,063 - $47,466	-1,170 Reduced 5.71%	19,310 $513,000
Q3 2021 Nov 03, 2021	SELL	$39.27 - $72.94 $203,418 - $377,829	-5,180 Reduced 20.19%	20,480 $841,000
Q2 2021 Aug 13, 2021	SELL	$31.29 - $56.64 $78,225 - $141,600	-2,500 Reduced 8.88%	25,660 $1.45 Million
Q1 2021 Apr 21, 2021	SELL	$39.71 - $90.58 $11,913 - $27,174	-300 Reduced 1.05%	28,160 $1.18 Million
Q4 2020 Feb 09, 2021	SELL	$27.07 - $84.35 $48,455 - $150,986	-1,790 Reduced 5.92%	28,460 $2 Million
Q3 2020 Oct 06, 2020	SELL	$28.06 - $37.16 $56,120 - $74,320	-2,000 Reduced 6.2%	30,250 $849,000
Q1 2020 May 15, 2020	SELL	$14.88 - $32.78 $7,812 - $17,209	-525 Reduced 1.6%	32,250 $640,000
Q4 2019 Feb 12, 2020	SELL	$19.49 - $32.63 $378,593 - $633,837	-19,425 Reduced 37.21%	32,775 $970,000
Q3 2019 Nov 13, 2019	SELL	$22.49 - $26.81 $130,441 - $155,498	-5,800 Reduced 10.0%	52,200 $1.19 Million
Q1 2019 May 09, 2019	SELL	$19.43 - $26.41 $530,069 - $720,491	-27,281 Reduced 31.99%	58,000 $1.42 Million
Q2 2018 Aug 14, 2018	SELL	$31.4 - $41.01 $6,280 - $8,202	-200 Reduced 0.23%	85,281 $0
Q4 2017 Jan 11, 2018	SELL	$21.89 - $31.34 $101,919 - $145,919	-4,656 Reduced 5.17%	85,481 $2.63 Million
Q3 2017 Nov 20, 2017	BUY	$15.81 - $24.01 $1.43 Million - $2.16 Million	90,137	90,137 $2.16 Million

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

Black Rock Inc. New York, NY

7.78M
Shares

$10.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$8.75 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.9M
Shares

$6.42 Million
0.62% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.35M
Shares

$4.39 Million
0.01% of portfolio
State Street Corp Boston, MA

2.46M
Shares

$3.23 Million
0.0% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.

Account